Segment Results (Schedule Of Reportable Segments Information) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014 segment		Sep. 30, 2013
Segment Reporting Information [Line Items]
Number of reportable segments (segments)					4
Total consolidated adjusted income before income tax	$ 329,480		$ 302,533		$ 882,680		$ 873,735
Total consolidated net revenues to external customers	763,938		661,319		2,077,231		2,031,961
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total consolidated net revenues to external customers	763,938		661,319		2,077,231		2,031,961
Branded Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Total consolidated adjusted income before income tax	130,613		224,747		395,446		635,168
Total consolidated net revenues to external customers	240,931		366,136		723,643		1,139,372
Generic Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Total consolidated adjusted income before income tax	139,497		48,630		318,528		141,720
Total consolidated net revenues to external customers	319,399		183,939		803,467		532,722
Devices [Member]
Segment Reporting Information [Line Items]
Total consolidated adjusted income before income tax	32,136		29,156		109,575		96,847
Total consolidated net revenues to external customers	109,822	[1]	111,244	[1]	359,425	[1]	359,867	[1]
Devices [Member] | United States [Member]
Segment Reporting Information [Line Items]
Total consolidated net revenues to external customers	73,429		75,484		230,530		233,091
Devices [Member] | International [Member]
Segment Reporting Information [Line Items]
Total consolidated net revenues to external customers	36,393		35,760		128,895		126,776
International Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Total consolidated adjusted income before income tax	27,234		0		59,131		0
Total consolidated net revenues to external customers	$ 93,786	[2]	$ 0	[2]	$ 190,696	[2]	$ 0	[2]
Minimum [Member]
Segment Reporting Information [Line Items]
Percentage of revenue from products accounted for more than 10% of total revenue	10.00%

[1] The following table displays our Devices segment revenue by geography for the three and nine months ended September 30, 2014 and 2013 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2014 2013 2014 2013Devices: United States$73,429 $75,484 $230,530 $233,091International36,393 35,760 128,895 126,776Total Devices revenues$109,822 $111,244 $359,425 $359,867

[2] Revenues generated by our International Pharmaceuticals segment are primarily attributable to Canada, Mexico and South Africa.